Scarica l'app Stockscreener
85.54
0.97%
0.82
Dopo l'orario di chiusura:
85.65
0.11
+0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$84.72
Aprire:
$84.54
Volume 24 ore:
5.30M
Relative Volume:
1.01
Capitalizzazione di mercato:
$125.63B
Reddito:
$15.91B
Utile/perdita netta:
$1.79B
Rapporto P/E:
104.32
EPS:
0.82
Flusso di cassa netto:
$1.69B
1 W Prestazione:
+1.16%
1M Prestazione:
+1.18%
6M Prestazione:
+17.42%
1 anno Prestazione:
+62.84%
Intervallo 1D:
$84.13
$85.69
Intervallo di 1 settimana:
$80.64
$85.69
Portata 52W:
$50.84
$88.79
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific to Speak at Conference - Baystreet.ca
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference - StockTitan
Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition - Medical Device Network
Gulf International Bank UK Ltd Lowers Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Sci to acquire Cortex, expand AF portfolio - BioWorld Online
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock - Investing.com
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock By Investing.com - Investing.com UK
TD Cowen maintains Buy rating on Boston Scientific with $100 target - Investing.com
Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI - GlobeNewswire Inc.
Are Wall Street Analysts Bullish On Boston Scientific Stock? - Barchart
Boston Scientific continues M&A run with Cortex buy - Yahoo Finance
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Earnings call: Boston Scientific focuses on cardiology growth and innovation - Investing.com India
Earnings call: Boston Scientific focuses on cardiology growth and innovation By Investing.com - Investing.com Canada
Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth - Insider Monkey
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX) - Yahoo Finance
Former Boston Scientific Exec Joins Transverse Medical’s Board - MPO-mag
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
The Zacks Analyst Blog The Progressive, Qualcomm, GE Aerospace, S&P Global and Boston Scientific - Zacks Investment Research
Boston Scientific Stock Gains From Market Expansion, Innovation - Yahoo Finance
J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree - MSN
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Looking for a Growth Stock? 3 Reasons Why Boston Scientific (BSX) is a Solid Choice - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction - Yahoo Finance
ACURATE study leaves Boston Scientific with lots of homework - BioWorld Online
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Dow Jones Composite Average (DOWC) QuotePress Release - The Globe and Mail
Up 45% YTD, Should You Buy This Outperforming Healthcare Stock? - MSN
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
TSX Composite Low Volatility (TXLV) QuotePress Release - The Globe and Mail
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific - Yahoo Finance
Why is Boston Scientific Stock Trading Lower On Wednesday? - Yahoo Finance
ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 - Quantisnow
Boston Scientific TAVR trial misses non-inferiority mark - Investing.com
Boston Scientific Co. (NYSE:BSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vaginal Mesh Lawsuits in 2024 - Lawsuit Information Center Blog
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Corporation (NYSE:BSX) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? - Yahoo Finance
Boston Scientific Corp. stock rises Monday, still underperforms market - MarketWatch
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people - Yahoo Finance
Boston Scientific Halts Key Trial for FARAPULSE System Amid Unexpected Complications - Yahoo Finance
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end - MSN
Boston Scientific raises FY24 adjusted EPS view to $2.45-$2.47 from $2.38-$2.42 - MSN
Axonic’s stock soars after cash buyout deal with Boston Scientific valued at $3.7 billion - MSN
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Boston Scientific Raises Full-Year Guidance After Third-Quarter Beat - MSN
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):